Cleveland Diagnostics is a company focused on developing diagnostic tests for the early detection of cancers. Its proprietary technology separates protein isoforms, allowing researchers to investigate proteins based on structure, not concentration. The company offers IsoPSA, a prostate-specific antigen for prostate cancer detection.